Alzheimer's Disease Trial, Recruiting (NCT06841848)

Alzheimer's Disease Trial, Recruiting NCT06841848 Sponsor: I.R.C.C.S. Fondazione Santa Lucia Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06841848 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 55 years of age or older.
For the Alzheimer's disease group: People who have been clinically diagnosed with mild to moderate Alzheimer's disease, confirmed by a memory and thinking test (called the MMSE, with a score between 10 and 26), as well as a brain scan (PET imaging) or a spinal fluid test (CSF).
For the control (comparison) group: People who have not been diagnosed with Alzheimer's disease or any other condition affecting the brain and nervous system over time.
People who are able to give their own written consent to participate. If there is any question about whether a person is mentally able to consent, an independent doctor or neurologist must first assess and confirm that they are capable before any study procedures begin.

Who may not be able to join:

People with severe memory and thinking difficulties (an MMSE score below 10) that would make it too difficult to cooperate during the imaging process.
People who are unable to stay still during the eye imaging procedure (fundus imaging).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390651501181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06841848

Sponsor: I.R.C.C.S. Fondazione Santa Lucia

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: +390651501181

More information: https://clinicaltrials.gov/study/NCT06841848

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 55 years of age or older.
For the Alzheimer's disease group: People who have been clinically diagnosed with mild to moderate Alzheimer's disease, confirmed by a memory and thinking test (called the MMSE, with a score between 10 and 26), as well as a brain scan (PET imaging) or a spinal fluid test (CSF).
For the control (comparison) group: People who have not been diagnosed with Alzheimer's disease or any other condition affecting the brain and nervous system over time.
People who are able to give their own written consent to participate. If there is any question about whether a person is mentally able to consent, an independent doctor or neurologist must first assess and confirm that they are capable before any study procedures begin.

Who may not be able to join:

People with severe memory and thinking difficulties (an MMSE score below 10) that would make it too difficult to cooperate during the imaging process.
People who are unable to stay still during the eye imaging procedure (fundus imaging).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

I.R.C.C.S. Fondazione Santa Lucia

Registry

ClinicalTrials.gov

Start date

1 May 2023

Est. completion

1 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Validation of Multispectral Fundus Imaging for Alzheimer's Disease Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov